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Abstract
Background: Early mother–child skin-to-skin contact (SSC) in the first 2 h postpartum is highly beneficial for both
mother and child. However, cases have been reported of newborns who have experienced apparently life-
threatening events (ALTEs) or sudden death during this procedure. The causes of these events are unknown.
Newborn’s prone position could influence the onset of these events but there is very little evidence to
support any recommendation. We hypothesize that newborns’ breathing obstruction episodes increase as
mothers lie more horizontally.
The main objective of this study is to compare the occurrence of desaturation and bradycardia episodes as
a function of mother’s bed incline.
The study is designed as a randomized, controlled, assessor blind, multicenter, superiority trial with two parallel groups
and 1:1 allocation ratio.
Methods: The study participants will be full-term healthy mother–newborn dyads from ten hospitals in Spain.
Participants will be randomly assigned to one of two study arms defined by mother’s bed inclination (45° or
15°). The planned sample size is 5866. Centralized permuted blocks randomization and assessor blinding will
be implemented.
The newborns will be monitored remotely with pulse oximetry, from 10min to 2 h after delivery. We established SO2
and heart rate (HR) limit alarms, as well as an action protocol in the event of alarm activation.
The primary outcome is the number of healthy newborns who undergo episodes of SO2≤ 90%. Secondary outcomes
are the mean SO2 level, the number of newborns who experience episodes of SO2 ≤ 85%, the time to SSC
discontinuation due to abnormal SO2 or HR, and episodes of HR < 111 beats per minute (bpm) or > 180 bpm.
Subgroups and pooled analysis will be performed to identify if breast-feeding and mother and child positions
favor the occurrence of desaturation or bradycardia episodes.
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Discussion: A simple intervention such as modifying mother’s bed angle of inclination while in SSC with her
child during the first 2 h postpartum could favor newborn’s hemodynamic and respiratory stabilization and
thus contribute to reducing the onset of ALTEs.
Trial registration: ClinicalTrials.gov, NCT02585492. Registered on 22nd October 2015.
Protocol version: 2 (30th June 2015).
Keywords: Pulse oximetry, Desaturation, Bradycardia, Tachycardia, Early skin-to-skin contact, Apparent life-
threatening events, Sudden death, Angle of inclination, Full-term newborns
Introduction
Background and rationale
Placing newborns in skin-to-skin contact (SSC) with
their mother’s abdomen immediately after birth is cur-
rently recommended. This intervention has been recom-
mended by the Baby Friendly Hospital Initiative [1] and
the American Academy of Pediatrics [2] and is listed in
Australian [3], Canadian [4], and British [5] guidelines.
In Spain, this intervention is recommended by, among
others, the Spanish Ministry of Health [6].
SSC promotes the establishment of an affective link
between parents and child, a crucial part of the child’s
survival and emotional development [7, 8]. SSC also
improves the mother’s perceptions of her child, her ma-
ternal skills, and the newborn’s physiological stability
[9–11]. The practice promotes the start and duration of
maternal lactation, prolonging it by a mean of 43 days.
Coinciding with the widespread use of this interven-
tion, however, cases have been reported of newborns
who have experienced apparent life-threatening events
(ALTEs) or sudden death in the first 2 h postpartum.
These newborns had a gestational age ≥ 37 weeks, were
born vaginally, and were apparently healthy [12–16].
These events have been reported in various countries
[16–27]. Although there are still no appropriate regis-
tries, the global incidence rate appears to vary between
2.5 and 3.2/100,000 births, and the mortality rate varies
between 0.8 and 1.8/100,000 births [16, 20]. The chil-
dren who survive these events frequently experience se-
vere neurological sequela [14, 15, 18, 19, 24–26].
The cause of these episodes is unknown [12, 13, 16,
17, 21, 22, 24], although the first 2 h after delivery are a
critical period for newborns. A number of authors con-
sider that newborns are more vulnerable to stressful
hypoxic factors during this period due to airway obstruc-
tions (a condition that could arise when lying in decubi-
tus prone on the mother’s body or breastfeeding) [12,
14, 16, 17, 19, 21, 25–27]. For other authors, these are
newborns with prenatal impairment not initially mani-
fested [20]. A number of authors have suggested that
these events could be explained by a predominance of
vagal tone during breastfeeding [13, 26]. These events
have been observed more frequently in primiparous
women, those who are tired or sleepy after delivery and
those who were not monitored properly during SSC or
while breastfeeding [12–17, 19–22, 24, 26, 27].
Due to the low incidence of ALTEs or sudden deaths
in the first 2 h of life in SSC, it is very difficult to con-
duct prospective studies that enable the assessment of
the efficacy of an intervention to prevent the ALTEs and
sudden deaths. However, the fact that these events occur
during the 2 h after delivery, a period in which most
newborns are in a healthcare center, makes it feasible to
design studies that evaluate the effect of various inter-
ventions on certain biological parameters that can be
continuously monitored, such as SO2 and HR. Instability
in either of these two parameters could precede these
devastating events.
We found no information in the reviewed literature on
the influence of the angle at which the mother’s bed is
inclined while in SSC on SO2 and HR outcomes. Only a
case study by Rodríguez-Alarcón et al. [27] recommends
that the mother sit at 30° to 45° above the horizontal
with a pillow behind the head but provides no informa-
tion from any study to justify this recommendation.
Given that the newborn’s prone position and the pres-
ence of circumstances that favor asphyxial episodes
could influence the onset of these events, we could pos-
tulate that the more the mother is inclined, the more
chances there are that the newborn will be in a situation
that obstructs breathing during this critical period of
life.
We therefore decided to conduct a randomized, multi-
center clinical trial to compare the number of healthy
newborns who experience episodes of SO2 ≤ 90% during
the first 2 h after birth while in SSC with their mother
while she is sitting up at a 45° or 15° angle above the
horizontal plane of the bed.
Objectives
The main objective is to compare the proportion of
healthy newborns who undergo at least one episode of
SO2 ≤ 90% between the two groups.
As secondary objectives, we will compare.
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– the mean SO2 level
– the proportion of newborns who experience at least
one episode of SO2 ≤ 85%
– the rate at which SSC is interrupted due to
abnormal SO2 or HR
– episodes of HR < 111 beats per minute (bpm) or >
180 bpm
An additional secondary objective will be to identify
positions for the mother and newborn that favor desat-
uration or bradycardia episodes.
Trial design
The study is designed as a randomized, controlled, asses-
sor blind, multicenter, superiority trial with two parallel
groups and 1:1 allocation ratio.
The study has been approved by the Clinical Research
Ethics Committee of the coordinating center (Hospital
12 de Octubre) and of each participating center. Additional




This study emerged from the research group setting of
the Spanish Collaborative Research Network for Mater-
nal and Child Health (SAMID Network; reference
RD12/0026/0007) and is financed by the Carlos III
Health Institute of Spain. Ten Spanish hospitals from
various regions and healthcare levels are participating in
the study, which together cover approximately 27,000
births a year. The coordinating center is Hospital 12 de
Octubre of Madrid. The research groups involved in the
study have experience in participating and coordinating
relevant European and international projects.
These hospitals have beds with adjustable tilt for the
women. Each of the centers is equipped with a remote
SO2 and HR monitoring system (Masimo Patient Safety-
Net®) for the newborns and have computer systems that
provide 24-h access to the study’s computer platform to
conduct the randomization and data entry into the elec-
tronic notebook. The mean number of researchers per
center is 10, with a range of 2–20.
Eligibility criteria for participants
All women who, at the start of labor, meet the inclusion
criteria and none of the exclusion criteria (prerandomi-
zation criteria) and who have signed the consent
form (see Additional file 2) will be included in the study
and randomized using an ad hoc computer platform. In
addition to the prerandomization exclusion criteria, we
have established postrandomization criteria that will re-
quire withdrawal from the study, given that some events
that occur during delivery may affect the newborn
Table 1 Prerandomization inclusion and exclusion criteria
Prerandomization inclusion criteria
Women who meet the following criteria at the start of labor are
considered candidates:
(a) pregnant with a single fetus
(b) monitored or partially monitored pregnancy (women who
underwent ultrasonography at week 20 of their pregnancy but not
during the first or third trimester or who did not undergo all trimester
laboratory tests)
(c) pregnancy proceeding normally or with mild disease (gestational
diabetes treated exclusively with diet or arterial hypertension [with no
diagnosis of preeclampsia] controlled with a single drug)
(d) end of pregnancy at full term (37+ 0–41+ 6 gestational age)
(e) temperature at start of labor ≤ 38 °C
(f) presence of companion during the 2 h after delivery
(g) mother’s wish for SSC
Prerandomization exclusion criteria
We excluded pregnant women before the randomization who met one
or more of the following criteria:
(a) consumption during pregnancy of tobacco, alcohol, drugs, or
medication with sedative effects (opioids, antiepileptic drugs,
antipsychotics, anxiolytics, hypnotics, antidepressants, and plants with
sedative effects)
(b) non-mild disease during pregnancy
(c) prenatal diagnosis of chromosomal disorders or major malformation
(d) prenatal diagnosis of intrauterine growth retardation with any
degree of flow impairment, as well as an “abnormal” fetal size for
gestational age (due to malformation, intrauterine infection, etc.)
(e) lack of companion during the first 2 h postpartum
Table 2 Postrandomization criteria for withdrawal from the study
Delivery related
(a) caesarean section or instrumental delivery (forceps, vacuum)
(b) maternal fever > 38 °C
(c) maternal hemodynamic instability (hypotension, tachycardia,
impaired consciousness, poor perfusion, notable pallor) or any other
type of ailment
(d) umbilical cord prolapsed
(e) signs of fetal “distress”, with fetal scalp pH < 7.25 or umbilical
artery pH < 7.20
(f) any other obstetric complication
(g) use of sedatives or relaxants during or after delivery
Neonate related
(a) need for resuscitation measures
(b) intrapartum-diagnosed major malformation
(c) Apgar score≤ 7 at 1, 5, or 10 min
(d) presence of symptoms before 10min of life
(e) birth weight < 2300 g or > 4500 g
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well-being. Table 1 lists the prerandomization inclusion
and exclusion criteria, and Table 2 lists the postrandomi-
zation withdrawal criteria. Once 10 min have passed,
and it is confirmed that none of the delivery- or
neonate-related postrandomization withdrawal criteria
have been met, all participating dyads will be included in
the primary analysis.
Interventions
Before starting patient enrollment, all participating cen-
ters have agreed upon the SSC procedure and the study
intervention. Additionally, the coordinating center has
conducted face-to-face training sessions in each of the
hospitals.
When a possible case is identified, consent from the
pregnant woman will be requested. Once the woman has
agreed to participate, she is shown a number of photo-
graphs of how to perform SSC (Fig. 1; “Models for
mother’s and newborn’s positions for 15° and 45°
inclination”). The woman is told to record the moment(s)
when the newborn latches on to the breast. The woman’s
data are subsequently entered into the computer platform
to proceed with the randomization. After the delivery, the
researcher attending the birth will verify that the case does
not meet any of the postrandomization withdrawal cri-
teria. The pulse oximetry apparatus (noninvasive
Radical-7 Signal Extraction PulseCO-Oximeter® monitor
equipped with Masimo Rainbow SET® technology) is then
plugged into the power outlet and to the data collection
and is subsequently turned on. The pulse oximeter alarms
have been established at 91% as the lower limit for SO2;
the upper limit has not been set. For the HR, the lower
limit alarm has been set to 111 bpm and the upper limit
to 180 bpm.
During the first 10 min after delivery, with the new-
born in SSC, the pulse oximeter sensor is attached
(Masimo, LNCS® Series Neo-L adhesive sensor) on the
right hand or wrist (preductal SO2). Considering the
Fig. 1 Models for mother’s and newborn’s positions for 15° and 45° inclination
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LNCS® sensor directions for use, the precision of the
sensors is ± 3% for SO2 with or without movement and
for the HR ± 3 bpm without movement and ± 5 bpm with
movement. The saturation accuracy of the neonate was
validated on adult volunteers and 1% was added to ac-
count for the properties of fetal hemoglobin. During these
first 10min after birth, the mother’s bed position is chan-
ged according to the corresponding randomization group
(45° or 15° above the horizontal). To standardize the inter-
vention, two cardboard models (15° and 45°) have been
manufactured that exactly reproduce the angle (Additional
file 1). During this period, diaper placement is the only
intervention allowed.
At 10 min after birth, the sensor cable is attached
to the pulse oximeter. After the connection, the pulse
oximeter begins continuously recording the HR and
SO2, storing the data and signal quality every 2 s. The
pulse oximeter remains connected to a central station
(Patient SafetyNet System, version V.4610, Masimo®)
next to the newborn and mother for the 2 h of the
study. The system transmits the data to the central
station in real-time every second, displaying them on
a monitor. The pulse oximeter’s alarms can be si-
lenced and the screen light turned off so as to disturb
the mother and newborn as little as possible. The
alarms can be silenced in both the monitor and pulse
oximeter. The pulse oximeter’s lighting can be reduced to
a minimum to disturb the mother and newborn as little as
possible. A practitioner is continuously monitoring the
display and can respond to an alarm. As a safety
mechanism, four locator-searchers (nurse, resident phys-
ician, staff physician, and supervising staff physician) pro-
vide alerts on the various alarms generated during the
recording.
During the intervention period, the newborns remain
at all times in SSC with their mother and will not
undergo any procedure. If the newborn is separated
from their mother for a reason other than those contem-
plated in the study (see alarm management protocol
below), the recording will be stopped and the newborn
will be removed from the study.
The mother may place a pillow behind her head but
not behind her back and may choose her position in the
bed, provided the assigned inclination angle is not chan-
ged (Fig. 1).
In those hospital centers in which the delivery and im-
mediate postpartum do not take place in the same room,
the transfer will be performed with the newborn in
skin-to-skin contact, and the time of the transfer will be
recorded. The monitor alarm, which will occur when
disconnecting the pulse oximeter, will thereby be
accounted for.
Action protocol in the event of an alarm or if a professional
assessment is requested
The protocol to be followed when an alarm sounds or
when a practitioner is requested to come assess the new-
born is shown in Fig. 2 (“Action protocol when an alarm
sounds or a professional assessment is requested”).
Fig. 2 Action protocol when an alarm sounds or a professional assessment is requested
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Table 3 shows the data that will be collected when vis-
iting the newborn for an assessment. The mother’s and
newborn’s positions will be documented according to a
series of model images created for each degree of inclin-
ation (Fig. 1; “Models for mother’s and newborn’s posi-
tions for 15° and 45° inclination”).
The practitioner will classify the alarm as clinical or
nonclinical depending on whether the events that justify
these alarms are clinical (CEs) or nonclinical events
(NCEs), respectively. The CEs can, in turn, be clinically
relevant (CREs) or nonclinically relevant events (NCREs).
NCEs do not entail that the intervention is terminated
and can occur due to excessive ambient light, problems
with the pulse oximeter’s connection cable or sensor,
low battery levels, interference, and lack of system con-
nectivity or availability.
The CEs include an SO2 < 91%, a HR > 180 bpm or <
111 bpm, and a newborn with symptoms. The protocol
to be followed when clinical alarm sounds is shown in
Figs. 3 and 4 (Fig. 3, action protocol when a SO2 < 91%
clinical alarm goes off; Fig. 4, action protocol when a HR
> 180 or < 111 bpm clinical alarm sounds). A CE is con-
sidered nonclinically relevant (NCRE) if the newborn is
asymptomatic and the event can be explained by a tech-
nical problem (insufficient signal capture) or by the new-
born’s condition at that moment (crying, newborn
handling by the mother, movement, etc.). NCREs do not
entail the termination of the intervention.
If the CE cannot be explained by any of the above
causes, the CE will be considered a CRE depending on
whether it occurs for the first or second time, the mag-
nitude of the desaturation, additional heart rate impair-
ment, or if the newborn is symptomatic. A CRE entails
the termination of the intervention.
Investigators at the coordinating center will review the
compliance with the intervention protocols. If noncom-
pliance is detected, the head of each participating center
will be contacted, and the deviations from the protocol
will be discussed.
Outcomes
The main outcome collected in both intervention groups
will be the proportion of healthy newborns who undergo
at least 1 episode of SO2 ≤ 90%.
The following secondary outcomes will also be
recorded:
Table 3 Data recorded in case of alarm or if a professional
assessment is requested
a. Number of alarms for this patient
b. SO2, HR, and time
c. Minimum SO2 during the episode and corresponding HR
d. Minimum or maximum HR as appropriate and corresponding SO2
e. Time to once again reach an SO2 > 90%
f. Position of the mother and child
g. Probable corresponding factor
h. Child’s clinical situation
i. If it entails terminating the procedure
j. Possibility of airway obstruction in the child
Fig. 3 Action protocol when a SO2 < 91% clinical alarm goes off
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(1) The mean SO2 level and HR in the first hour, in the
second hour, and for both hours combined.
(2) The proportion of newborns who undergo at least
one episode of SO2 ≤ 85%.
(3) The proportion of SSC interruption due to a
medical indication.
(4) The number of HR episodes < 111 bpm and > 180
bpm.
(5) The mother’s posture (right lateral decubitus, left
lateral decubitus, or supine) and that of her child
(right lateral decubitus, left lateral decubitus,
supine, or prone) at the time of the episode of
SO2 ≤ 90% or HR < 111 bpm.
Participant timeline
The participant timeline is shown in Fig. 5.
Sample size and recruitment
We conducted an observational pilot study in the coord-
inating center. In this study, the mothers performed SSC
with their child in the first 2 h postpartum, and there
was no intervention on the maternal position adopted.
The mothers could choose their position, partially sitting
up with an angle between 15° and 50°. We observed that
approximately one of every ten healthy newborns had an
episode of SO2 ≤ 90%.
To calculate the study’s sample size, we predetermined
that, with the bed in the 15° and 45° positions, the rate of
episodes could be 9% and 6%, respectively. To estimate a
reduction of a third in the number of newborns with
episodes of SO2 ≤ 90% (with a 95% confidence level and a
power of 80%), we calculated that we would need to in-
clude 1275 newborns in each group, which represented a
total of 2550 newborns. In the pilot study, we observed
that approximately 50% of the initially included cases had
to be excluded due to established postrandomization cri-
teria (see Table 2). Therefore, the estimated number of
dyads to randomize would be 5100. We deemed it neces-
sary to include 15% more participants for operational rea-
sons and to conduct an intermediate analysis. The final
figure for participants would therefore be 5866.
This number would be easily recruitable among all the
centers involved in the study. The recruitment will last
32 months.
Allocation and blinding
The randomization was conducted using permuted
blocks. To this end, we employed a shared computer
platform. Each center was assigned a block, and the pa-
tients were randomized one after another according to
the random numbers contained in the corresponding
block. Each center’s block size was created after an ini-
tial calculation of the number of mother/newborn dyads
the center could recruit over the course of a month (the
block sizes ranged from 193 to 1076 cases). The patients
will be randomized at the start of labor. Once the in-
formed consent form is signed, the researcher who ob-
tained the consent will access the shared computer
platform with the center’s specific login. The platform
will then take the researcher directly to their block of
Fig. 4 Action protocol when a HR > 180 or < 111 bpm clinical alarm sounds
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random numbers and show them the mother’s degree of
inclination. Beforehand, the researcher must answer a
series of questions to confirm that the dyad meets all
study inclusion criteria and none of the exclusion cri-
teria. The center’s researcher is not allowed to know the
block of numbers they are given nor the sequence of
numbers. The recorded pulse oximetry data (SO2 and
HR) will be extracted and analyzed in the coordinating
center by researchers who will be blinded to the
mother’s sitting angle in bed.
Data collection, management, and monitoring
In each case, a number of characteristics related to the
mother, delivery, and newborn will be recorded (Table 4).
These data will be inserted a posteriori in the electronic
case report form created for the study and will be
accessible for those responsible for the study in the co-
ordinating center. The recorded information corre-
sponding to the SO2 and HR for each case will be
electronically downloaded through various report for-
mats, which in turn will be submitted to the coordinat-
ing center by e-mail. The coordinating center has the
appropriate software for reading and analyzing the re-
corded pulse oximetry data.
The implementation of post-randomization exclusion
criteria will be evaluated in a reliability study. Two in-
vestigators will independently assess the criteria in a
sub-sample of study participants. Reliability and agree-
ment statistics will be reported.
Statistical methods
As we estimate a relevant proportion of estimated post-
randomization exclusions, we will perform a modified
intention to treat analysis.
The study will employ a two-tailed significance level of
5%. The confidence intervals will be 95%. The main as-
sessment criterion is the presence of an episode of SO2 ≤
90%. We will perform an unadjusted analysis of the in-
tervention’s effect with chi-squared test.
The distribution of the baseline prognostic variables
will be analyzed with the mean and standard devi-
ation for the continuous variables (we expect a nor-
mal distribution) and with numerators/denominators
and percentages for the categorical variables. P values
Fig. 5 SPIRIT. Schedule of enrollment, interventions, and assessments
Table 4 Demographic data to be recorded in each case
- Mother-related: age, country of origin, medical history of interest, parity,
desire to breastfeed, increase in weight during pregnancy, body mass
index, bra size (including cup size), a history of children who died, and
medication consumed during the 72 h prior to delivery
- Delivery-related: date and time, duration, time of completion,
spontaneous or induced, delivery position, epidural anesthesia, time of
epidural, time the water broke, nuchal cord, episiotomy, artery and
umbilical vein blood gas test, maternal medication during labor and 2
h afterwards.
- Neonate-related: sex, weight, gestational age, Apgar score, cord pH,
presence of crying at birth, and time of the first breast latch
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will not be included, but we will indicate the variables
that have a strong association that could have a con-
founding effect—even if the distributions in the two
study groups are not very different—and the variables
with large differences between the groups that could
have a confounding effect, even those with a poor as-
sociation. Stratified analysis and logistic regression
modeling will be performed on the primary outcome
to take into account covariates (i.e., exploring the
possible effect of modification of breast feeding,
adjusting for relevant covariates, etc.). The strategies
for missing-data imputation and the subgroup analysis
will be documented a priori.
The statistical analysis will be conducted using the
software environment R [28].
An independent committee, which will include an in-
dependent biostatistician, will review the results of the
interim analysis.
The study will be halted if differences in the main out-
come show a p value below 0.001 to protect the overall
type I error of the trial. The study will also be inter-
rupted on safety grounds due to any other results that
show a negative effect on the child or mother considered
relevant by the committee.
Ethical aspects
Problems were detected after an initial pilot trial. A
meeting was held with all centers from which emerged
proposals for changing the initial trial protocol. These
changes were presented to the coordinating center’s
Clinical Research Ethics Committee (EC), who approved
the changes (2015-06-30), which were then sent to the
ethics committees of the participating hospitals, who in
turn approved the changes.
One of the required inclusion criteria is that the mother
must have a companion during the first 2 h postpartum,
given that the episodes have been more frequently re-
ported when the mothers were not accompanied during
this period. There is currently no recommendation on the
ideal position for the mother and child immediately after
delivery. Therefore, neither of the two positions in the
study differ from any standard nor change the established
risk. In current standard practice, newborns in SSC are
not monitored.
The principles of the Declaration of Helsinki will be
respected during the project’s implementation. All docu-
mentation generated by the study shall be treated, com-
municated, and transferred in accordance with the
requirements laid out in the Spanish Organic Law 15/
1999 of December 13 on the Protection of Personal
Data. Documentation confidentiality will be ensured.
The study protocol was submitted for approval to the
Clinical Research Ethics Committee of Hospital 12 de
Octubre and those of the other participating centers. A
single informed consent (Additional file 2) form was
prepared for the women who decided to participate in
the study. If a woman decides to withdraw her consent
for participating in the study, no new datum will be
added, and she may request the erasing of her already
recorded data.
Each of the participating centers has a researcher re-
sponsible for guarding and updating all information gen-
erated by the trial in their hospital, both for hardcopy
and electronically generated information. At the coord-
inating center, this researcher will be responsible not
only for the data produced in their hospital but also for
that submitted by each center regarding the reports on
the records of the enrolled cases.
The results of this study will be published in pediatric
journals in the top 10% in terms of impact factor. Fur-
thermore, all information and results from the trial will
be presented in national and international scientific
meetings. Once the study has concluded, the results will
be recorded on the Clinicaltrials.gov website in which it
is registered.
Discussion
This randomized clinical trial seeks to show whether the
mother’s sitting position at 45° or 15° above the horizon-
tal plane influences the full-term newborn’s cardiopul-
monary stability without complications while in SSC
during the first 2 h postpartum. The results of this study
will provide information on the newborns’ risk of ALTEs
or sudden death while this procedure is performed in
the abovementioned time interval.
All etiological hypotheses consider that newborns (in
the first 2 h after delivery) are susceptible to hypoxic epi-
sodes, either from a central origin or by obstructive
problems [12–14, 16, 17, 19–21, 25–27]. Except for the
study by Davanzo et al. [29], no prospective studies in
the scientific literature have assessed the circumstances
that could contribute to the onset of hypoxic episodes in
the first 2 h of life.
This study, which uses the methodology of a clinical
trial, will be the first to assess whether the mother’s bed
incline in the immediate postpartum could influence the
onset of desaturation episodes and/or changes in the HR
in the newborn. In the SSC position, the newborn is
usually in decubitus prone on their mother. It is easy to
assume that the more reclined the mother, the greater
the possibility of compromising the newborn’s breathing,
even more so during the first 2 h of life, a critical period
for adapting to extrauterine life. This study will also as-
sess the role of breastfeeding during SSC in the onset of
these events.
This clinical trial is the first to continuously monitor
SO2 levels and HR during the first 2 h postpartum in
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full-term newborns with no complications and delivered
vaginally who are in SSC with their mother.
Our understanding of the progression of SO2 in new-
borns in SSC is scarce. A number of studies have exam-
ined the SO2 range of full-term healthy newborns, but
only during the first minutes of life. It has been observed
that newborns have low SO2 levels that increase slowly,
without generally reaching the 90% level after 5 min
[30–33]. Other observations have noted a significant
gradient between the SO2 of preductal oxygen (higher)
and postductal oxygen during the first 15 min after de-
livery [32, 33]. There is no uniformity in terms of the
time needed to achieve an SO2 of 90% between new-
borns born by caesarean section and those born vagi-
nally [31, 33–35]. In terms of the progression of SO2 in
full-term newborns in SSC, our understanding is much
lower. Dawson [36] reported that a mean of 7.9 min
(interquartile range, 5.0–10.0 min) is required to achieve
an SO2 > 90%. Takahashi [37] studied the progression of
SO2 and HR for 30 min in two groups of newborns. In
the first group, SSC was started during the first 5 min
after delivery. In the other group, SSC was started after
5 min or more. The group that started SSC earlier
achieved HR stability sooner (between 120 and 160
bpm), but there were no differences in terms of SO2 sta-
bility (readings between 92% and 96%).
Other factors that contribute to the relevance of this
study are that it focuses on a clinical problem of consid-
erable significance for the health of the newborn who
experiences this condition, one that has been reported in
practically all developed countries. In addition, currently
available information on this problem is very scarce [14,
15, 18, 19, 24–26]. This is the first time this problem has
been approached with a clinical trial design, with a mul-
ticenter approach and a considerable sample size. An-
other point of interest is that these potential risk
situations will be documented with model images.
Based on the study results, a preventive strategy for
these episodes of sudden death and ALTEs could be de-
signed. If keeping the mothers in a more upright pos-
ition is associated with a lower rate of desaturation in
the newborn, the change in maternal position could act
as a protective factor for ALTEs and sudden deaths in
the first 2 h.
The study is multicenter, which could entail certain
variability in a number of the study procedures despite
previous agreements, which could represent a limitation.
Thus, in the hospitals in which the delivery and postpar-
tum take place in different rooms, the pulse oximeter
will be disconnected while the mother and child are
transferred, and there will be a loss of data during this
time interval. The SSC procedure itself or the method
for achieving proper bed inclination might not be uni-
form. Lastly, the clinical practice of the various centers
regarding the clamping of the umbilical cord (early or
late clamping, umbilical cord milking) varies. Another
limitation consists of the fact that the study will not have
the services of a contract research organization (CRO).
The coordinating center’s researchers will be responsible
for monitoring the proper application of the study
protocol.
The study results may not be applicable to newborn
groups with different characteristics but who are still
candidates for SSC (late-preterm newborns, newborns
with disease during the pregnancy, and/or delivery that
does not contraindicate SSC).
One of the study risks is that it can lead to the moni-
toring of all newborns during their time in SSC and po-
tentially to separating many newborns from their
mothers. This is not the study’s objective, which seeks
only to observe the effect of the bed position.
The study is focused on analyzing what occurs during
the first 2 h after delivery. It would be interesting to ex-
tend the analysis time to the first 24 h of life while the
mother and child are in SSC. It would also be important
to determine whether the degree of inclination could in-
fluence the mother’s recovery and state of health during
the immediate postpartum.
Even if the results of this study can shed some light on
our understanding of these events, they will not preclude
medical personnel from continuing to give mothers and
their companions the recommendations that various ex-
perts have indicated in terms of safely implementing
SSC [12, 13, 15, 16, 20–22, 24, 27, 29, 38, 39].
Trial status The trial has completed the planning and
pilot phases and is currently enrolling participants. The
first patient was recruited in November 2015.
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